| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CFO | President And CFO
1 company
Guggenhime Andrew is a President And CFO at Vaxcyte, Inc.. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $5.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2024 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 8,000 | $61.27 | $490,199.41 | -4.0% | +34.2% | -49.4% | |
| Mar 18, 2024 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 8,000 | $69.02 | $552,143.75 | -4.0% | +5.6% | +9.8% | |
| Feb 20, 2024 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 8,000 | $74.53 | $596,231.64 | -3.2% | +2.5% | +12.5% | |
| Jan 18, 2024 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 8,000 | $60.73 | $485,878.63 | -2.4% | +2.6% | +40.2% | |
| Dec 18, 2023 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 8,000 | $60.18 | $481,416.77 | -4.8% | +12.7% | +48.9% | |
| Dec 14, 2023 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 14,000 | $60.22 | $843,080.00 | -15.0% | +20.9% | +44.8% | |
| Nov 20, 2023 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 8,000 | $51.13 | $409,062.92 | -4.8% | +44.1% | +69.4% | |
| Oct 18, 2023 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 8,000 | $45.91 | $367,300.31 | -4.8% | +34.2% | +151.2% | |
| Sep 19, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 3,100 | $26.10 | $80,897.88 | -3.9% | +64.8% | +93.0% | |
| Aug 29, 2022 | PCVX Vaxcyte, Inc. | President And CFO | Sale+OE | 36,000 | $28.00 | $1,008,000.00 | -22.1% | +57.8% | +85.7% |